Talking Points on Deprescribing in Hospice Care

Deepak Shrivastava (UC Davis School of Medicine, Sacramento, California, USA)

$120

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press
23 April 2024

Medical ethics & professional conduct; Public health & preventive medicine; Palliative medicine; Psychiatry

Deprescribing practice in hospice medicine has expanded exponentially in recent years. This book systematically addresses the groups of extremely useful medications to manage chronic disease conditions and prevent complications. It highlights the positive intervention of reducing polypharmacy, improving a terminally ill patient's quality of life, providing individual patient context and helping clinicians in deprescribing. It discusses good ethics, patient wishes and side effect protocols to discontinue no longer relevant medications, thus improving decision-making with the goal of enhancing the patient's quality of life during the time when it is needed the most.

Key Features:

Empowers the patient, their families, and the providers to have an open discussion about well-informed decision-making. Equips the hospice and palliative care clinicians to comfortably explain the rationale and the discontinuation process of the unessential medications. Highlights the most important facts in bullets along with a unique feature of providing ready-to-go conversational phrases.

By: Deepak Shrivastava (UC Davis School of Medicine Sacramento California USA)
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions: Height: 198mm, Width: 129mm,
Weight: 510g
ISBN: 9781032491080
ISBN 10: 1032491086
Pages: 169
Publication Date: 23 April 2024
Audience: College/higher education , Professional and scholarly , Primary , Undergraduate
Format: Hardback
Publisher's Status: Active

Introduction Physiologic changes of terminal illness Fundamentals of deprescribing Deprescribing Statins Deprescribing Benzodiazepines Deprescribing Antipsychotics Deprescribing SSRI and SNRIs Deprescribing Tricyclic Antidepressants Deprescribing Anticholinergic drugs for parkinsonism Deprescribing Anticholinergic drugs for urinary incontinence Deprescribing muscle relaxants Deprescribing long-term Opioids Deprescribing Proton Pump Inhibitors Deprescribing Allopurinol Deprescribing Antihyperglycemics Oral Deprescribing Antihyperglycemics Injectable Deprescribing anti-hypertensives Deprescribing Anticoagulants Deprescribing Cholinesterase inhibitors Deprescribing Glaucoma eye drops Deprescribing Vitamin D and Calcium Deprescribing NSAIDs Deprescribing gabapentin and pregabalin Deprescribing long-acting Beta agonist Deprescribing Vitamins Deprescribing medications in children Deprescribing in Transgender and LGBTQ Cultural competency in deprescribing Chaplain and medical social worker When to restart discontinued medications. Medicolegal aspects of deprescribing

Deepak Shrivastava, MD is a board-certified Hospice Medical Director. In addition, he holds board certifications in Internal Medicine, Sleep Medicine, Pulmonary and Critical Care Medicine and Post-Acute and Long-Term Care. He is an academic and clinical faculty at the Sleep, Critical Care and Pulmonary division. He is a Clinical Professor at the University of California. He is an adjunct Professor of Pharmacy at the University of Pacific, School of Pharmacy. He is the recipient of many academic and service awards including the Medical Director of the Year award (2015) at the American Medical Directors Association. Dr. Shrivastava received his training at the State University of New York, University of California, Davis and Stanford. He is an active researcher with a keen interest in medical education. He is directly involved in health care quality and performance improvement. In addition to his active practice of Pulmonary, Critical Care and Sleep Medicine in an ACGME-accredited teaching program, he has been involved in Medicare Hospice Benefit Program since 1989. He is a member of the National Partnership for Healthcare and Hospice Innovation (NPHI). His areas of interest are clinical nursing and hospice physician education, and performance improvement in hospice care.